A management shakeup at Covidien plc has installed a new chief for the Irish company’s surgical devices operation, which has a plant in North Haven.
The Dublin healthcare products maker said Wednesday the leadership changes, effective July 1, will streamline its organization to accelerate growth and innovation.
Scott Flora, who led the surgical devices division as president the past five years, is leaving Covidien to pursue other career opportunities, the company said.
Bryan C. Hanson will become group president, with responsibility for the surgical devices and energy-based devices businesses. Hanson joined Covidien in 1992 and has held several positions of increasing responsibility, including his current position as president of energy-based devices.
Peter L. Wehrly will become group president overseeing the respiratory and monitoring solutions and vascular therapies businesses, as well as regional responsibility for Japan, Australia-New Zealand and Canada. Wehrly joined Covidien in 2009.
Michael Sgrignari will become senior vice president, quality and operations, with global responsibility for quality assurance, regulatory affairs, logistics, environmental health and safety and operational excellence. Sgrignari joined Covidien in 1991.
All three will all report to José (Joe) E. Almeida, currently president of medical devices and Covidien’s CEO-elect. His current post will be eliminated, but medical devices will remain an external reporting segment, the company said.
Meanwhile, James M. Muse, senior vice president of global supply chain, will retire after 32 years.
